ATE245983T1 - Inhibitoren der nuklearen lokalisierung von hiv - Google Patents

Inhibitoren der nuklearen lokalisierung von hiv

Info

Publication number
ATE245983T1
ATE245983T1 AT98940874T AT98940874T ATE245983T1 AT E245983 T1 ATE245983 T1 AT E245983T1 AT 98940874 T AT98940874 T AT 98940874T AT 98940874 T AT98940874 T AT 98940874T AT E245983 T1 ATE245983 T1 AT E245983T1
Authority
AT
Austria
Prior art keywords
hiv
nuclear localization
inhibitors
genus
compounds
Prior art date
Application number
AT98940874T
Other languages
English (en)
Inventor
Senliang Pan
Michael Bukrinsky
Omar K Haffar
Original Assignee
Picower Inst Med Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Picower Inst Med Res filed Critical Picower Inst Med Res
Application granted granted Critical
Publication of ATE245983T1 publication Critical patent/ATE245983T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT98940874T 1997-08-15 1998-08-13 Inhibitoren der nuklearen lokalisierung von hiv ATE245983T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/912,076 US5808068A (en) 1997-08-15 1997-08-15 HIV nuclear localization inhibitors
PCT/US1998/016814 WO1999009014A1 (en) 1997-08-15 1998-08-13 Hiv nuclear localization inhibitors

Publications (1)

Publication Number Publication Date
ATE245983T1 true ATE245983T1 (de) 2003-08-15

Family

ID=25431342

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98940874T ATE245983T1 (de) 1997-08-15 1998-08-13 Inhibitoren der nuklearen lokalisierung von hiv

Country Status (8)

Country Link
US (1) US5808068A (de)
EP (1) EP1012146B1 (de)
JP (1) JP4475487B2 (de)
AT (1) ATE245983T1 (de)
AU (1) AU758464B2 (de)
CA (1) CA2300424C (de)
DE (1) DE69816835T2 (de)
WO (1) WO1999009014A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6297253B1 (en) * 1996-10-15 2001-10-02 The Picower Institute For Medical Research Compounds and methods of use to treat infectious diseases
CA2475189C (en) * 2003-07-17 2009-10-06 At&T Corp. Method and apparatus for window matching in delta compressors
US20050203150A1 (en) * 2004-03-09 2005-09-15 Haffar Omar K. Compounds, compositions and methods for inhibiting or treating HIV-1

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0673022A (ja) * 1992-08-27 1994-03-15 Kumiai Chem Ind Co Ltd ピリミジンまたはトリアジン誘導体及び除草剤

Also Published As

Publication number Publication date
AU8905498A (en) 1999-03-08
JP2001515069A (ja) 2001-09-18
WO1999009014A1 (en) 1999-02-25
EP1012146B1 (de) 2003-07-30
EP1012146A1 (de) 2000-06-28
DE69816835T2 (de) 2004-04-22
CA2300424C (en) 2009-04-07
JP4475487B2 (ja) 2010-06-09
CA2300424A1 (en) 1999-02-25
AU758464B2 (en) 2003-03-20
US5808068A (en) 1998-09-15
EP1012146A4 (de) 2002-12-04
DE69816835D1 (de) 2003-09-04

Similar Documents

Publication Publication Date Title
NO893834D0 (no) Terapeutiske forbindelser for aids basert paa hemmere av hiv-protease.
TR28718A (tr) Dinamik takilan tipte cocuk bezi.
FI951059A (fi) HIV-aspartyyliproteaasin sulfonamidi-inhibiittoreita
ATE241350T1 (de) Transdermale verabreichungsform von flurbiprofen
DE68913638D1 (de) Behandlung von wässerigen Systemen.
FI893962A0 (fi) Vid vaord av aids anvaendbara hiv-proteas -inhibitorer.
DK0674513T3 (da) Retroviral protease-inhiberende forbindelser
DK172389D0 (da) Hiv-proteaseinhibitorer, der er nyttige til behandling af aids
ES2041681T3 (es) Tratamiento de infecciones fungosas.
FI953954A (fi) HIV:n käänteistranskriptaasin inhibiittoreita
DE68907423D1 (de) Behandlung der akne.
ES2160874T3 (es) Agentes herbicidas sinergicos.
NO892820D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive amidino-og guanidino-derivater.
NO932130D0 (no) Hemmere av hiv-protease som er nyttige for behandling av aids
FI945199A0 (fi) HIV-käänteiskopioijaentsyymin uudet kinatsoliini-inhibiittorit
DE69816835D1 (de) Inhibitoren der nuklearen lokalisierung von hiv
DE3750344D1 (de) Beschleuniger der Aktivität von Hydrolase.
RU94045248A (ru) Способ ингибирования активности вируса иммунодефицита человека (hiv) in vivo
DE69332904T2 (de) Hemmung von hiv-infektion
ATE75610T1 (de) Pharmazeutische zubereitung zur behandlung des bluthochdrucks.
BR8905052A (pt) Aparelho de destruicao localizada de estructuras moles
FI896159A0 (fi) Valsanordning med en undervals med hydrauliskt innerstoed.
UA6147A1 (uk) 2-(2,7-діацетоксіфлуореніліден-9-гідразоно)-5гептілідентіазолідон-4, що виявляє протигрипозну дію відносно віруса грипу а та а-2
NO960551D0 (no) Antistoff basert behandling av HIV infeksjon
UA6149A1 (uk) 2-(2'7'-діацетоксіфлуореніліден-9'-гідразоно)-5-(п-нітробензіліден)-тіазолідон-4,що виявляє противірусну дію щодо віруса грипу а та а-2, а також віруса осповакцини

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties